Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-015838

Chief Executive Officer sold 5,675 shares at $232.10 ($1,317,191)

  • Chief Executive Officer acquired 5,675 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-15 Exercise or conversion : show line 1 in the form 10b5-1 +5,675 $57.76 $327,788 442,605 D
2023-05-15 Sale : show line 2 in the form 10b5-1 −5,675 $232.10 $1,317,191 436,930 D
Open-market sales · 5,675 sh · avg $232.10 · $1,317,191

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-15 Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options −5,675 37,515 D
Loading xslF345X04/form4.xml…